MetaADEDB 2.0 @ LMMD
riociguat
(WXXSNCNJFUAIDG-UHFFFAOYSA-N)
Structure
SMILES
COC(=O)N(c1c(N)nc(nc1N)c1nn(c2c1cccn2)Cc1ccccc1F)C
Type(s)
Approved
ATC code(s)
C02KX05
Molecular Formula:
C20H19FN8O2
Molecular Weight:
422.416
Log P:
3.6051
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
2
TPSA:
138.07
CAS Number(s):
625115-55-1; 1304478-72-5
Synonym(s)
1.
riociguat
2.
Adempas
3.
BAY 63-2521
4.
BAY-63-2521
External Link(s)
MeSHC542595
PubChem Compound11304743
ChEBI76018
CHEMBLCHEMBL2107834
DrugBankDB08931
DrugCentral4807
IUPHAR/BPS Guide to PHARMACOLOGY5257
KEGGdr:D09572
Therapeutic Target DatabaseD04UKC
ZINC3819392
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DizzinessFAERS: 159
Canada Vigilance: 70
Canada Vigilance
SIDER
US FAERS
2HypotensionFAERS: 150
Canada Vigilance: 46
Canada Vigilance
SIDER
US FAERS
3HeadacheFAERS: 141
Canada Vigilance: 27
Canada Vigilance
SIDER
US FAERS
4NauseaFAERS: 115
Canada Vigilance: 25
Canada Vigilance
SIDER
US FAERS
5FatigueFAERS: 88
Canada Vigilance: 47
Canada Vigilance
US FAERS
6Peripheral swellingFAERS: 83
Canada Vigilance: 33
Canada Vigilance
US FAERS
7PneumoniaFAERS: 82
Canada Vigilance: 20
Canada Vigilance
US FAERS
8VomitingFAERS: 78
Canada Vigilance: 11
Canada Vigilance
SIDER
US FAERS
9SyncopeFAERS: 52
Canada Vigilance: 9
Canada Vigilance
US FAERS
10Chest PainFAERS: 49
Canada Vigilance: 11
Canada Vigilance
US FAERS
11MalaiseFAERS: 49
Canada Vigilance: 33
Canada Vigilance
US FAERS
12Drug dose omissionFAERS: 47US FAERS
13DyspepsiaFAERS: 47
Canada Vigilance: 13
Canada Vigilance
SIDER
US FAERS
14AstheniaFAERS: 46
Canada Vigilance: 32
Canada Vigilance
US FAERS
15ConstipationFAERS: 41
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
16Feeling abnormalFAERS: 37
Canada Vigilance: 19
Canada Vigilance
US FAERS
17Pulmonary HypertensionFAERS: 36
Canada Vigilance: 7
Canada Vigilance
US FAERS
18Product use issueFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
19Abdominal PainFAERS: 31
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
20Pulmonary arterial hypertensionFAERS: 29US FAERS
21Product dose omissionFAERS: 26
Canada Vigilance: 22
Canada Vigilance
US FAERS
22Drug ineffectiveFAERS: 24
Canada Vigilance: 7
Canada Vigilance
US FAERS
23NasopharyngitisFAERS: 23
Canada Vigilance: 23
Canada Vigilance
US FAERS
24Abdominal discomfortFAERS: 22
Canada Vigilance: 9
Canada Vigilance
US FAERS
25Adverse eventFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
26Joint swellingFAERS: 22
Canada Vigilance: 8
Canada Vigilance
US FAERS
27PainFAERS: 22
Canada Vigilance: 7
Canada Vigilance
US FAERS
28Urinary tract infectionFAERS: 22
Canada Vigilance: 5
Canada Vigilance
US FAERS
29Weight decreasedFAERS: 22
Canada Vigilance: 8
Canada Vigilance
US FAERS
30ArthralgiaFAERS: 21
Canada Vigilance: 5
Canada Vigilance
US FAERS
31DehydrationFAERS: 21
Canada Vigilance: 4
Canada Vigilance
US FAERS
32InfluenzaFAERS: 21
Canada Vigilance: 6
Canada Vigilance
US FAERS
33Respiratory FailureFAERS: 21US FAERS
34PalpitationsFAERS: 20
Canada Vigilance: 9
Canada Vigilance
SIDER
US FAERS
35SwellingFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
36General physical health deteriorationFAERS: 19
Canada Vigilance: 4
Canada Vigilance
US FAERS
37Intestinal ObstructionFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
38EpistaxisFAERS: 17
Canada Vigilance: 7
Canada Vigilance
SIDER
US FAERS
39Acute kidney injuryFAERS: 16US FAERS
40Chest discomfortFAERS: 16
Canada Vigilance: 8
Canada Vigilance
US FAERS
41Back PainFAERS: 15
Canada Vigilance: 10
Canada Vigilance
US FAERS
42SepsisFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
43TachycardiaFAERS: 15US FAERS
44Atrial FibrillationFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
45Cerebrovascular accidentFAERS: 14
Canada Vigilance: 4
Canada Vigilance
US FAERS
46AscitesFAERS: 13US FAERS
47FlatulenceFAERS: 12US FAERS
48HypoxiaFAERS: 12US FAERS
49Product availability issueFAERS: 12US FAERS
50Pulmonary endarterectomyFAERS: 12
Canada Vigilance: 6
Canada Vigilance
US FAERS
51ThrombosisFAERS: 12
Canada Vigilance: 5
Canada Vigilance
US FAERS
52Blood potassium decreasedFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
53Pericardial effusionFAERS: 11US FAERS
54Right ventricular failureFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
55Therapy cessationFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
56Unevaluable eventFAERS: 11US FAERS
57FlushingFAERS: 10US FAERS
58Intentional product use issueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
59LethargyFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
60MyalgiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
61PresyncopeFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
62Pulmonary EmbolismFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
63SomnolenceFAERS: 10
Canada Vigilance: 4
Canada Vigilance
US FAERS
64Wrong technique in product usage processFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
65AnxietyFAERS: 9
Canada Vigilance: 6
Canada Vigilance
US FAERS
66EndarterectomyFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
67Fluid overloadFAERS: 9US FAERS
68GastroenteritisFAERS: 9SIDER
US FAERS
69Incorrect dose administeredFAERS: 9
Canada Vigilance: 4
Canada Vigilance
US FAERS
70Myocardial InfarctionFAERS: 9US FAERS
71Productive CoughFAERS: 9
Canada Vigilance: 8
Canada Vigilance
US FAERS
72AlopeciaFAERS: 8US FAERS
73Cardiac ArrestFAERS: 8US FAERS
74Product supply issueFAERS: 8US FAERS
75PruritusFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
76Rehabilitation therapyFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
77VertigoFAERS: 8US FAERS
78WheezingFAERS: 8US FAERS
79GoutFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
80HypersensitivityFAERS: 7US FAERS
81Intentional product misuseFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
82Oxygen supplementationFAERS: 7US FAERS
83Pulmonary thrombosisFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
84Respiratory distressFAERS: 7US FAERS
85TremorFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
86Unresponsive to stimuliFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
87Blood count abnormalFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Depressed moodFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
89Device related infectionFAERS: 6US FAERS
90Disease ProgressionFAERS: 6US FAERS
91Feeling ColdFAERS: 6
Canada Vigilance: 6
Canada Vigilance
US FAERS
92Hospice CareFAERS: 6US FAERS
93Inappropriate schedule of drug administrationFAERS: 6US FAERS
94Musculoskeletal PainFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
95Respiratory arrestFAERS: 6US FAERS
96intensive careFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
97AphasiaFAERS: 5US FAERS
98Blood pressure fluctuationFAERS: 5
Canada Vigilance: 13
Canada Vigilance
US FAERS
99Burning sensationFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
100ErythemaFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
101GastritisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
102Mechanical ventilationFAERS: 5US FAERS
103Oropharyngeal painFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
104SinusitisFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
105Traumatic fractureFAERS: 5US FAERS
106Accidental exposure to product by childFAERS: 4US FAERS
107Blood glucose decreasedFAERS: 4US FAERS
108Blood potassium increasedFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
109Blood urine presentFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
110ChokingFAERS: 4US FAERS
111Clostridium difficile infectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Cold sweatFAERS: 4US FAERS
113Critical IllnessFAERS: 4US FAERS
114CystitisFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
115Drug administered to patient of inappropriate ageFAERS: 4US FAERS
116DysphoniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
117DysuriaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
118Emotional disorderFAERS: 4US FAERS
119Gastric DilatationFAERS: 4US FAERS
120HerniaFAERS: 4US FAERS
121InflammationFAERS: 4US FAERS
122LacerationFAERS: 4US FAERS
123Limb discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Limb injuryFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
125Loss of personal independence in daily activitiesFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
126NervousnessFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
127Product prescribing issueFAERS: 4US FAERS
128Pulmonary painFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
129UrticariaFAERS: 4US FAERS
130Visual ImpairmentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
131Acute respiratory failureFAERS: 3US FAERS
132AmnesiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
133AngioplastyFAERS: 3US FAERS
134Ankle FractureFAERS: 3US FAERS
135BronchitisFAERS: 3
Canada Vigilance: 7
Canada Vigilance
US FAERS
136CellulitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
137ChillsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
138CryingFAERS: 3US FAERS
139DeafnessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
140DiscomfortFAERS: 3US FAERS
141DisorientationFAERS: 3US FAERS
142Drug titration errorFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
143DysgeusiaFAERS: 3US FAERS
144EructationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
145FractureFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Head discomfortFAERS: 3
Canada Vigilance: 4
Canada Vigilance
US FAERS
147Hepatic EncephalopathyFAERS: 3US FAERS
148HydronephrosisFAERS: 3US FAERS
149Inappropriate schedule of product administrationFAERS: 3
Canada Vigilance: 6
Canada Vigilance
US FAERS
150Incorrect product administration durationFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
151InfectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
152Intra-abdominal fluid collectionFAERS: 3US FAERS
153Joint injuryFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
154Medical procedureFAERS: 3US FAERS
155Memory impairmentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Neck PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
157OverdoseFAERS: 3US FAERS
158PneumonitisFAERS: 3US FAERS
159Post procedural complicationFAERS: 3US FAERS
160Procedural complicationFAERS: 3US FAERS
161Procedural hypotensionFAERS: 3US FAERS
162RalesFAERS: 3US FAERS
163SluggishnessFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
164Sudden deathFAERS: 3US FAERS
165Therapy changeFAERS: 3US FAERS
166Throat irritationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
167TransplantFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
168Troponin increasedFAERS: 3US FAERS
169AbasiaFAERS: 2US FAERS
170Abnormal weight gainFAERS: 2US FAERS
171Accidental exposure to productFAERS: 2US FAERS
172Ammonia increasedFAERS: 2US FAERS
173Angina PectorisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
174AngioedemaFAERS: 2US FAERS
175Anticoagulation drug level increasedFAERS: 2US FAERS
176AnuriaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Arterial thrombosisFAERS: 2US FAERS
178AsphyxiaFAERS: 2US FAERS
179AsthmaFAERS: 2US FAERS
180BlindnessFAERS: 2US FAERS
181Blood iron decreasedFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
182Blood sodium decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
183BradyphreniaFAERS: 2US FAERS
184CardiomegalyFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
185Cerebral InfarctionFAERS: 2US FAERS
186Choking sensationFAERS: 2US FAERS
187Clostridium difficile colitisFAERS: 2US FAERS
188ColitisFAERS: 2US FAERS
189Cor pulmonaleFAERS: 2US FAERS
190Deep Vein ThrombosisFAERS: 2US FAERS
191Dialysis device insertionFAERS: 2US FAERS
192Drug dispensing errorFAERS: 2US FAERS
193Ear discomfortFAERS: 2
Canada Vigilance: 4
Canada Vigilance
US FAERS
194EpilepsyFAERS: 2US FAERS
195Extra dose administeredFAERS: 2US FAERS
196Feeling jitteryFAERS: 2US FAERS
197Flank PainFAERS: 2US FAERS
198Food PoisoningFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
199Gait inabilityFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
200Gastric ulcerFAERS: 2US FAERS
201Gastrointestinal PainFAERS: 2SIDER
US FAERS
202Hepatic necrosisFAERS: 2US FAERS
203HypophagiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
204IleusFAERS: 2US FAERS
205Incorrect product storageFAERS: 2US FAERS
206Incorrect route of drug administrationFAERS: 2US FAERS
207Increased tendency to bruiseFAERS: 2US FAERS
208Increased viscosity of bronchial secretionFAERS: 2US FAERS
209InfarctionFAERS: 2US FAERS
210Limb massFAERS: 2US FAERS
211Lip swellingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
212LymphomaFAERS: 2US FAERS
213MalnutritionFAERS: 2US FAERS
214Medication ErrorFAERS: 2US FAERS
215MenorrhagiaFAERS: 2US FAERS
216Musculoskeletal stiffnessFAERS: 2US FAERS
217NephrolithiasisFAERS: 2US FAERS
218NeuralgiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
219Ocular icterusFAERS: 2US FAERS
220Oropharyngeal discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
221Pain of skinFAERS: 2US FAERS
222PallorFAERS: 2US FAERS
223Peritoneal DialysisFAERS: 2US FAERS
224PhotophobiaFAERS: 2US FAERS
225Physical product label issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
226Pleuritic painFAERS: 2US FAERS
227PneumothoraxFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
228PolyuriaFAERS: 2US FAERS
229Product packaging issueFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
230Pulmonary congestionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
231Pulmonary function test decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
232RhonchiFAERS: 2US FAERS
233SclerodermaFAERS: 2US FAERS
234Seizure like phenomenaFAERS: 2US FAERS
235Skin lesionFAERS: 2US FAERS
236Skin tightnessFAERS: 2US FAERS
237Sputum retentionFAERS: 2US FAERS
238TensionFAERS: 2US FAERS
239Terminal stateFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
240ThrombectomyFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
241ThrombocytosisFAERS: 2US FAERS
242UlcerFAERS: 2US FAERS
243Upper-airway cough syndromeFAERS: 2US FAERS
244Urinary IncontinenceFAERS: 2US FAERS
245Viral upper respiratory tract infectionFAERS: 2US FAERS
246Walking distance test abnormalFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
247White blood cell count decreasedFAERS: 2US FAERS
248Abdominal tendernessFAERS: 1US FAERS
249Activities of daily living impairedFAERS: 1US FAERS
250Acute myocardial infarctionFAERS: 1US FAERS
251Airway secretion clearance therapyFAERS: 1US FAERS
252Alcohol abuseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
253Aortic stent insertionFAERS: 1US FAERS
254ApathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
255Apparent deathFAERS: 1US FAERS
256Application site reactionFAERS: 1US FAERS
257Arteriovenous fistula site complicationFAERS: 1US FAERS
258ArthritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
259ArthropathyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
260AtelectasisFAERS: 1US FAERS
261Atrial FlutterFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
262Autoimmune hepatitisFAERS: 1US FAERS
263Back disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
264BendopnoeaFAERS: 1US FAERS
265Bilevel positive airway pressureFAERS: 1US FAERS
266BiopsyFAERS: 1US FAERS
267Bladder prolapseFAERS: 1US FAERS
268Blood glucose increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
269Blood magnesium decreasedFAERS: 1US FAERS
270Blood pressure inadequately controlledFAERS: 1US FAERS
271Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
272Body TemperatureFAERS: 1US FAERS
273Bone contusionFAERS: 1US FAERS
274Bone painFAERS: 1US FAERS
275BradycardiaFAERS: 1US FAERS
276Brain natriuretic peptide abnormalFAERS: 1US FAERS
277Brain natriuretic peptide increasedFAERS: 1US FAERS
278Breast discomfortFAERS: 1US FAERS
279Cardiac ablationFAERS: 1US FAERS
280Cardiac discomfortFAERS: 1US FAERS
281Cardiac dysfunctionFAERS: 1US FAERS
282Cardiac procedure complicationFAERS: 1US FAERS
283Cardiovascular evaluationFAERS: 1US FAERS
284Carpal Tunnel SyndromeFAERS: 1US FAERS
285CataractFAERS: 1US FAERS
286Catheter site dischargeFAERS: 1US FAERS
287Catheter site pruritusFAERS: 1US FAERS
288Cervix carcinomaFAERS: 1US FAERS
289CholecystitisFAERS: 1US FAERS
290CholelithiasisFAERS: 1US FAERS
291CholestasisFAERS: 1US FAERS
292ColectomyFAERS: 1US FAERS
293Complication associated with deviceFAERS: 1US FAERS
294Complications of transplant surgeryFAERS: 1US FAERS
295Concomitant disease progressionFAERS: 1US FAERS
296Contraindicated drug prescribedFAERS: 1US FAERS
297Contraindicated product administeredFAERS: 1US FAERS
298Creatinine renal clearance decreasedFAERS: 1US FAERS
299CyanosisFAERS: 1US FAERS
300DementiaFAERS: 1US FAERS
301Device battery issueFAERS: 1US FAERS
302Device dislocationFAERS: 1US FAERS
303Device leakageFAERS: 1US FAERS
304Diabetic FootFAERS: 1US FAERS
305Diffuse alveolar damageFAERS: 1US FAERS
306DisabilityFAERS: 1US FAERS
307DiverticulitisFAERS: 1US FAERS
308Drug DependenceFAERS: 1US FAERS
309Drug dose titration not performedFAERS: 1US FAERS
310Drug effect delayedFAERS: 1US FAERS
311Drug effect incompleteFAERS: 1US FAERS
312Dry skinFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
313DysarthriaFAERS: 1US FAERS
314DysbacteriosisFAERS: 1US FAERS
315Ear congestionFAERS: 1US FAERS
316Early satietyFAERS: 1US FAERS
317Economic problemFAERS: 1US FAERS
318EnteritisFAERS: 1US FAERS
319EosinophiliaFAERS: 1US FAERS
320Epigastric discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
321Erection increasedFAERS: 1US FAERS
322Essential TremorFAERS: 1US FAERS
323Exfoliative rashFAERS: 1US FAERS
324Eye inflammationFAERS: 1US FAERS
325Eye painFAERS: 1US FAERS
326Facial PainFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
327Feelings of worthlessnessFAERS: 1US FAERS
328Food AllergyFAERS: 1US FAERS
329Frustration tolerance decreasedFAERS: 1US FAERS
330Gastric Antral Vascular EctasiaFAERS: 1US FAERS
331Gastric StenosisFAERS: 1US FAERS
332Gastric mucosal lesionFAERS: 1US FAERS
333Gastric ulcer helicobacterFAERS: 1US FAERS
334Gastrointestinal inflammationFAERS: 1US FAERS
335Gastrointestinal obstructionFAERS: 1US FAERS
336Gastrointestinal sounds abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
337Gastrointestinal ulcerFAERS: 1US FAERS
338Genital rashFAERS: 1US FAERS
339Grip strength decreasedFAERS: 1US FAERS
340HyperpyrexiaFAERS: 1US FAERS
341HypersomniaFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
342Hypertensive crisisFAERS: 1US FAERS
343HyperthyroidismFAERS: 1US FAERS
344HypertrophyFAERS: 1US FAERS
345HysterectomyFAERS: 1US FAERS
346Impaired gastric emptyingFAERS: 1US FAERS
347Impaired quality of lifeFAERS: 1US FAERS
348Inability to afford medicationFAERS: 1US FAERS
349IncoherentFAERS: 1US FAERS
350Increased bronchial secretionFAERS: 1US FAERS
351Intentional dose omissionFAERS: 1US FAERS
352Intervertebral disc compressionFAERS: 1US FAERS
353Intestinal Pseudo-ObstructionFAERS: 1US FAERS
354Irritable Bowel SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
355Lactose IntoleranceFAERS: 1US FAERS
356LaryngitisFAERS: 1US FAERS
357Liver AbscessFAERS: 1US FAERS
358Low Cardiac Output SyndromeFAERS: 1US FAERS
359Lower respiratory tract infectionFAERS: 1
Canada Vigilance: 4
Canada Vigilance
US FAERS
360LymphadenopathyFAERS: 1US FAERS
361Lymphocyte count decreasedFAERS: 1US FAERS
362LymphopeniaFAERS: 1US FAERS
363Manufacturing product shipping issueFAERS: 1US FAERS
364Maternal exposure during pregnancyFAERS: 1US FAERS
365Medical device discomfortFAERS: 1US FAERS
366Medical device removalFAERS: 1US FAERS
367Medical induction of comaFAERS: 1US FAERS
368Mental impairmentFAERS: 1US FAERS
369Mental status changesFAERS: 1US FAERS
370Metabolic acidosisFAERS: 1US FAERS
371Micturition frequency decreasedFAERS: 1US FAERS
372Migraine with AuraFAERS: 1US FAERS
373Mineral supplementationFAERS: 1US FAERS
374Multiple allergiesFAERS: 1US FAERS
375Muscle strainFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
376Muscle tightnessFAERS: 1US FAERS
377MydriasisFAERS: 1US FAERS
378MyelofibrosisFAERS: 1US FAERS
379Nasal discomfortFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
380Neutrophil count decreasedFAERS: 1US FAERS
381NoduleFAERS: 1US FAERS
382Occult blood positiveFAERS: 1US FAERS
383Oral fungal infectionFAERS: 1US FAERS
384Orthostatic intoleranceFAERS: 1US FAERS
385Oxygen saturation abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
386PCO2 increasedFAERS: 1US FAERS
387PancreatitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
388ParacentesisFAERS: 1US FAERS
389Paranasal sinus hypersecretionFAERS: 1US FAERS
390PericarditisFAERS: 1US FAERS
391PeritonitisFAERS: 1US FAERS
392PetechiaeFAERS: 1US FAERS
393Platelet count abnormalFAERS: 1US FAERS
394PleurisyFAERS: 1US FAERS
395PolyneuropathyFAERS: 1US FAERS
396Poor quality sleepFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
397Post-traumatic painFAERS: 1US FAERS
398Post-tussive vomitingFAERS: 1US FAERS
399Product dosage form issueFAERS: 1US FAERS
400Product use in unapproved indicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
401Pulmonary EosinophiliaFAERS: 1US FAERS
402Pulmonary FibrosisFAERS: 1US FAERS
403Pulmonary arterial pressure abnormalFAERS: 1US FAERS
404Pulmonary arterial pressure increasedFAERS: 1US FAERS
405Rectal ObstructionFAERS: 1US FAERS
406Respiratory tract congestionFAERS: 1US FAERS
407Restless Legs SyndromeFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
408RestlessnessFAERS: 1US FAERS
409RetchingFAERS: 1US FAERS
410RhinitisFAERS: 1US FAERS
411Scleroderma renal crisisFAERS: 1US FAERS
412Septic ShockFAERS: 1US FAERS
413ShockFAERS: 1US FAERS
414Skin UlcerFAERS: 1US FAERS
415Skin lacerationFAERS: 1US FAERS
416Slow response to stimuliFAERS: 1US FAERS
417SneezingFAERS: 1US FAERS
418Spinal column injuryFAERS: 1US FAERS
419StressFAERS: 1
Canada Vigilance: 3
Canada Vigilance
US FAERS
420Suicide attemptFAERS: 1US FAERS
421Swelling of eyelidFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
422Therapeutic response unexpectedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
423Thermal burnFAERS: 1US FAERS
424ThrombocytopeniaFAERS: 1US FAERS
425TinnitusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
426Toe operationFAERS: 1US FAERS
427Tooth ExtractionFAERS: 1US FAERS
428Toxicity to various agentsFAERS: 1US FAERS
429Tracheostomy malfunctionFAERS: 1US FAERS
430Transaminases increasedFAERS: 1US FAERS
431Transfusion ReactionFAERS: 1US FAERS
432TuberculosisFAERS: 1US FAERS
433Urinary RetentionFAERS: 1US FAERS
434Urinary hesitationFAERS: 1US FAERS
435Venoocclusive diseaseFAERS: 1US FAERS
436Ventilation perfusion mismatchFAERS: 1US FAERS
437Vessel perforationFAERS: 1US FAERS
438Vitreous DetachmentFAERS: 1US FAERS
439Vitreous floatersFAERS: 1US FAERS
440Wound ComplicationFAERS: 1US FAERS
441Wound InfectionFAERS: 1US FAERS
442Wrong drug administeredFAERS: 1US FAERS
443Wrong technique in drug usage processFAERS: 1US FAERS
444nervous system disorderFAERS: 1SIDER
US FAERS
445AgeusiaCanada Vigilance: 1Canada Vigilance
446Anticoagulation drug level below therapeuticCanada Vigilance: 1Canada Vigilance
447AppendicitisCanada Vigilance: 1Canada Vigilance
448BedriddenCanada Vigilance: 1Canada Vigilance
449Bladder neoplasm surgeryCanada Vigilance: 1Canada Vigilance
450Blood creatinine increasedCanada Vigilance: 1Canada Vigilance
451Breast cancer recurrentCanada Vigilance: 1Canada Vigilance
452Cataract operationCanada Vigilance: 4Canada Vigilance
453ChemotherapyCanada Vigilance: 1Canada Vigilance
454Chronic sinusitisCanada Vigilance: 1Canada Vigilance
455Depressed Level of ConsciousnessCanada Vigilance: 1Canada Vigilance
456DiverticulumCanada Vigilance: 1Canada Vigilance
457DyscheziaCanada Vigilance: 1Canada Vigilance
458EcchymosisCanada Vigilance: 1Canada Vigilance
459EmbolismCanada Vigilance: 1Canada Vigilance
460Feeling of body temperature changeCanada Vigilance: 1Canada Vigilance
461Gait deviationCanada Vigilance: 1Canada Vigilance
462Gastrointestinal viral infectionCanada Vigilance: 1Canada Vigilance
463HepatitisCanada Vigilance: 1Canada Vigilance
464Increased upper airway secretionCanada Vigilance: 1Canada Vigilance
465InfestationSIDER
466Infrequent bowel movementsCanada Vigilance: 1Canada Vigilance
467Initial insomniaCanada Vigilance: 1Canada Vigilance
468Iron deficiencyCanada Vigilance: 1Canada Vigilance
469Labile blood pressureCanada Vigilance: 1Canada Vigilance
470Living in residential institutionCanada Vigilance: 1Canada Vigilance
471Lung cystCanada Vigilance: 1Canada Vigilance
472Macular degenerationCanada Vigilance: 1Canada Vigilance
473Middle insomniaCanada Vigilance: 1Canada Vigilance
474Musculoskeletal discomfortCanada Vigilance: 2Canada Vigilance
475Nasal PolypsCanada Vigilance: 1Canada Vigilance
476Nasal inflammationCanada Vigilance: 1Canada Vigilance
477NephritisCanada Vigilance: 1Canada Vigilance
478OnychalgiaCanada Vigilance: 1Canada Vigilance
479Oxygen consumption decreasedCanada Vigilance: 1Canada Vigilance
480PharyngitisCanada Vigilance: 2Canada Vigilance
481Product administration errorCanada Vigilance: 1Canada Vigilance
482Pulmonary arterial pressure decreasedCanada Vigilance: 1Canada Vigilance
483Pulmonary artery therapeutic procedureCanada Vigilance: 2Canada Vigilance
484RadiculopathyCanada Vigilance: 1Canada Vigilance
485RegurgitationCanada Vigilance: 1Canada Vigilance
486Renal painCanada Vigilance: 1Canada Vigilance
487Rotator cuff syndromeCanada Vigilance: 1Canada Vigilance
488SplenomegalyCanada Vigilance: 1Canada Vigilance
489StomatitisCanada Vigilance: 1Canada Vigilance
490Throat cancerCanada Vigilance: 1Canada Vigilance
491TonsillitisCanada Vigilance: 1Canada Vigilance
492Transfusion-related circulatory overloadCanada Vigilance: 1Canada Vigilance
493Vascular device infectionCanada Vigilance: 1Canada Vigilance
494Walking aid userCanada Vigilance: 1Canada Vigilance
495Wheelchair userCanada Vigilance: 1Canada Vigilance
496White Coat HypertensionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.